Innovation Birmingham Campus-based digital health scale-up, Breaking Free Group, has been announced as one of just 26 exciting new British businesses selected for the prestigious Commonwealth Export Champions programme.
Belfast’s millennials win opportunity to join ‘Shaping Davos’ live discussion at WEF’s Annual Summit in Switzerland
For the first time, Belfast will be shaping the agenda of internationally renowned think-tank, the World Economic Forum (WEF) Annual Summit in Davos, Switzerland (17th – 20th January).
Cardiff based Alesi Surgical Announces Japanese Regulatory Approval for Ultravision and Exclusive Agreement with Adachi Co Ltd.
Alesi Surgical, a leading innovator of advanced minimally invasive surgery technologies, based at Cardiff Medicentre and Adachi Co., Ltd. today announce regulatory approval of the Ultravision™ visual field clearing system by the Japanese Ministry of Health, Labour and Welfare and an exclusive agreement in Japan.
Instruction leaflets are confusing at the best of times. But they could be a matter of life and death if you’ve just been diagnosed with a chronic disease and suddenly need to learn fast how to inject yourself with vital medication.
Over 3,500 new jobs will be created and 75,000 sq m of research and development and clinical space will be delivered at the Cambridge Biomedical Campus after proposals from joint developers Liberty Property Trust and Countryside were approved by Cambridge City Council.
With the price of patching up potholes warned to reach tipping point this year, researchers have found using infrared heating to repair roads could save millions.
Road repair bills in England and Wales could reach £14bn in two years, dwarfing councils’ highway £4.4bn budgets, the Local Government Association says.
The government said councils will get £10m a year from a new pothole repair fund, but the Local Government Association warns this won’t pay for a big backlog.
A protein that controls cell division also has a key role switching genes on and off, scientists have found, in a discovery which could reinvent cancer treatment.
The protein phosphatase, Repo-Man is one of a clutch of key proteins in cell division, an essential process that goes into overdrive in cancer.
Now researchers at Brunel University London have found Repo-Man is also crucial in controlling mechanisms that switch genes on or off after cells divide.
UK Solar Car Racing Team Signs Cfms As Sponsor, Gets Access To Cray Supercomputer For Car Design Modelling
The UK based solar racing team, Solar Team Great Britain, that is aiming to be the first British team to win the Bridgestone World Solar Challenge, has today announced it has signed the Centre for Modelling & Simulation (CFMS), a specialist in high value design capability, as a strategic sponsor.
A BioCity Nottingham based scientist hopes to create jobs and retain top talent in Nottingham by making the city a major centre for a sustainable new form of farming – after winning a scholarship awarded by the Nottingham Post.
Dhaval Patel, of BioCity-based firm Azotic Technologies, hopes that studying an executive master of business administration (EMBA) course at Nottingham Business School will enable him to transfer scientific research that creates biofertlizer into profitable products for agriculture.
Sygnature Discovery and Pelago Bioscience collaborate to provide CETSA based Target Engagement Assays
Sygnature Discovery (Sygnature), the UK’s largest independent provider of integrated drug discovery resource and expertise, today announced that it will collaborate with Swedish biotech company, Pelago Bioscience, to provide target engagement assays with Pelago’s patented Cellular Thermal Shift Assay (CETSA®) method.